Plain-English translation of NCT07162675 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether the amount you move each day—measured by a smartwatch—can predict how well your breast cancer responds to chemotherapy given before surgery. This is an observational study, meaning you'll wear a smartwatch and answer some questionnaires, but you won't be assigned to take a new medication. The study is trying to learn whether activity levels and sleep quality are early signals that treatment is working.
Doctors know that physical activity and sleep are important for cancer outcomes, but they don't usually have real-time data about these factors during treatment. This study wants to test whether wearable devices can provide that information and help predict who will respond best to therapy, so doctors can potentially tailor care better in the future.
You likely qualify if…
You likely don't qualify if…
You would wear a Huawei smartwatch that continuously tracks your daily steps, heart rate, and sleep throughout your cancer treatment. At the start and end of your chemotherapy, you'll complete questionnaires about your sleep quality and overall quality of life. Researchers will then compare your activity levels and sleep patterns to how well your cancer responds to treatment, as measured by surgery findings.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Turkey (Türkiye)